Ophthalmology Doctors in Savannah, GA Accepting Medicare

27 Ophthalmology doctors found. Showing 21 - 27

Dr. Elizabeth Helen Landa, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8 Stephenson Ave, Savannah, GA 31405 Phone: 912-355-1091    Fax: 912-352-7378

Dr. Eugene B Mclaurin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 415 Eisenhower Dr, Suite 5, Savannah, GA 31406 Phone: 912-355-9020    Fax: 912-355-9040

Sanford Rosenthal, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 4720 Waters Ave, Savannah, GA 31404 Phone: 912-354-4800    Fax: 912-629-5821

Dr. Michael Steven Landa, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8 Stephenson Ave, Savannah, GA 31405 Phone: 912-355-1091    Fax: 912-352-7378

John Michael Devaro, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 340 Eisenhower Dr. Bldg 1400, Suite A, Savannah, GA 31406 Phone: 912-353-1001    Fax: 912-353-1026

Robert T King Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4720 Waters Ave, Savannah, GA 31404 Phone: 912-354-4800    Fax: 912-629-4821

Dr. Judith M Piros, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 E Jackson Blvd, Savannah, GA 31405 Phone: 912-352-7941    Fax: 912-352-7946

News Archive

Study results confirm safety and efficacy of INSIGHTEC's Exablate Neuro system for the treatment of essential tremor

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, has announced that the New England Journal of Medicine (NEJM) has published the results of a pivotal study of their Exablate Neuro system for the non-invasive treatment of essential tremor (ET). The study met its primary endpoint with patients treated with Exablate Neuro demonstrating a clinically significant 47% improvement in a composite tremor score at three months as compared to no change in the sham cohort.

Sinapis Pharma completes Bridge financing to continue support drug development program

Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program. Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology. The company has strong pre-clinical data in stroke and traumatic brain injury animal models conclusively demonstrating a 12-hour therapeutic window and multiple pathway neuroprotection.

Tenet Healthcare board to review Community Health Systems' revised all-cash proposal

Tenet Healthcare Corporation today confirmed that it has received a revised proposal from Community Health Systems, Inc. to acquire all of the outstanding shares of Tenet for $6.00 per share in cash.

AnaptysBio announces issuance of two new patents for SHM-XEL platform

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.

Humana's profit shrinks on higher expenses

The insurer said it expects to add more customers to its Medicare Advantage and individual plan businesses. Meanwhile, a few hospitals say they are doing simple surgeries for some uninsured patients for free to keep their problems from turning into emergencies that would be more expensive to treat, and those who developed meningitis as a result of tainted products seek compensation.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)